Epigeneron is a biotechnology and manufacturing startup founded in 2015. The company recently secured a ¥48.00M Series B investment on 11 March 2021 from 東北大学ベンチャーパートナーズ株式会社. This funding marks a significant milestone for the company, as it continues to develop innovative solutions in the biotechnology and manufacturing industries. As Epigeneron advances with its cutting-edge technologies, this latest investment is expected to propel the company towards further growth and success in the competitive market.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | ¥48.00M | 1 |
|
11 Mar 2021 |
| Series B | ¥320.00M | 2 |
|
17 Sep 2020 |
| Venture Round | Unknown | 1 |
|
12 Mar 2018 |
We care about your data, and we'd love to use cookies make your experience better.
